NCT07128147Not yet recruiting
Detection of Helicopacter Pylori in Patients With Metabolic Associated Fatty Liver Disease
Source: ClinicalTrials.gov · Last updated 13 Jan 2026
Brief summary (registry, in English)
Owing to the correlation between H.pylori and MAFLD, our study aims to search for H.pylori in every patient with MAFLD to aid in the management of MAFLD and improve quality of life for these patients by decreaseing morbidity and mortality.
- Status (registry)
- Not yet recruiting
- Study type
- Observational
- Enrollment
- 200 (estimated)
- First submitted
- 27 Jul 2025
- Start date
- 1 Sept 2026
- Primary completion date
- 1 Sept 2026
- Lead sponsor
- Assiut University
- Diseases
- Fatty liver disease (MASLD/MASH)
- NCT number
- NCT07128147
What you commit to
- Study type: Observational
- Planned participants: 200
- From 1 Sept 2026 to the primary completion date, 1 Sept 2026
- No sites listed in no country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Previous history of alcohol consumption, steroids, proton pump inhibitors, antibiotics, and contraceptive pills.
Other illness
- Presence of malignancy.
Age
- Patients aged ≤18 years old.
Other
- Pregnancy.
- Type I DM.
- Patients with fatty liver who undergone bariatric surgeries.
Who the study is looking for
- All patients aged \>18 years old.
- Was diagnosed as MAFLD based on abdominal ultrasonography (US) or other imaging techniques.
Age in the registry: 18 years to 60 years · Sex: All · Accepts healthy volunteers
This page is information, not medical advice. Discuss any trial with your doctor.